Table 4 Univariate and multivariate analyses of associations between various parameters and cancer-specific survival.
From: Myosteatosis as a novel prognostic biomarker after radical cystectomy for bladder cancer
Variable | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Age | 1.00 | 0.97–1.04 | 0.58 | |||
Male | 0.86 | 0.47–1.57 | 0.64 | |||
≥ ECOG PS 1 | 2.20 | 1.18–4.10 | 0.01 | 2.05 | 1.04–4.04 | 0.03 |
≥ CCI 1 | 1.23 | 0.75–2.03 | 0.40 | |||
Psoas muscle index | 0.87 | 0.72–1.04 | 0.13 | |||
Average psoas muscle density | 0.96 | 0.93–0.99 | < 0.01 | 0.96 | 0.94–0.99 | 0.03 |
Neoadjuvant chemotherapy | 0.95 | 0.54–1.65 | 0.85 | |||
non-UC (vs. UC) | 3.60 | 1.90–6.83 | < 0.01 | 2.26 | 1.15–4.43 | 0.01 |
≥ pT3 | 4.40 | 2.60–7.43 | < 0.01 | 2.98 | 1.68–5.27 | < 0.01 |
pN positivity | 2.75 | 1.60–4.73 | < 0.01 | 2.26 | 1.25–4.08 | < 0.01 |
Concurrent CIS | 0.69 | 0.35–1.37 | 0.29 | |||
